Clinical Study of the Ginko biloba -Troxerutin-Heptaminol Hcet in the Treatment of Acute Hemorrhoidal Attacks
KANIT SUMBOONNANONDA, MD, FRCSEd*, PANUWA T LERTSITHICHAI, MD, MSc*
Affiliation : *Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand. t Ginko biloba-Troxerutin-Heptaminol Hce = Ginkor Fort® (Beaufour Ipsen International, Thailand).
Objective :The aim of this study was to assess the clinical efficacy, compliance and safety of Ginko biloba - Troxerutin-Heptaminol Hce in the treatment of patients with acute hemorrhoidal attacks in Thailand.
Materials and Methods : In a prospective clinical study on hospital outpatients, the authors studied the effect of Ginko biloba-Troxerutin-Heptaminol Hce for a week in adults (18-70 years old) with acute hemorrhoidal attacks. Result :Twenty-two patients, with a mean age of 41.7 years were included in the study. The male to female ratio was 1 : 1.2. Most patients (77%) had grade 1 and 2 hemorrhoids with an average duration of attacks of 3 days. On intention to treat analysis, bleeding, pain, tenesmus and discharge were significantly improved. Treatment was well accepted and safe.
Conclusion : In the short-term, Ginko biloba -Troxerutin-Heptaminol Hce is effective, accept able and safe in the treatment of patients with acute hemorrhoidal attacks.
Keywords : Acute Hemorrhoidal Attacks, Ginko Biloba-Troxerutin-Heptaminol Hce
